TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+40.91%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$685M
AUM Growth
+$685M
(+86%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
23.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$190M |
Top Sells
| 1 |
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
|
$25.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $285M | 41.58% |
9,024,031
| – | – |
|
|
2
Pliant Therapeutics
PLRX
$101M
| $190M | 27.66% |
+5,839,160
| New | +$190M |
|
3
Fulcrum Therapeutics
FULC
$351M
| $109M | 15.92% |
5,962,202
| – | – |
|
4
Voyager Therapeutics
VYGR
$186M
| $80.7M | 11.77% |
6,391,176
| – | – |
|
|
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $21M | 3.07% |
3,048,780
| – | – |
|
|
NTGN
6
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| – | – |
-9,741,636
| Closed | -$25.7M |
|